Genocea Biosciences Inc Share Price Nasdaq
Equities
US3724271040
Biotechnology & Medical Research
Sales 2020 | 1.36M 113M | Sales 2021 | 1.64M 137M | Capitalization | 66.64M 5.56B |
---|---|---|---|---|---|
Net income 2020 | -43M -3.59B | Net income 2021 | -33M -2.75B | EV / Sales 2020 | 50.8 x |
Net cash position 2020 | 55.9M 4.66B | Net cash position 2021 | 19.96M 1.67B | EV / Sales 2021 | 28.4 x |
P/E ratio 2020 |
-2.18
x | P/E ratio 2021 |
-2.4
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 01/07/01 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 10/18/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 11/14/11 |
1st Jan change | Capi. | |
---|---|---|
+16.02% | 45.51B | |
-9.63% | 38.52B | |
+38.08% | 38.13B | |
+27.91% | 30.74B | |
-8.64% | 26.03B | |
+11.66% | 25.92B | |
+44.88% | 14.13B | |
+33.59% | 12.73B | |
-7.88% | 11.29B |